Literature DB >> 3199137

Should the posterior cruciate ligament be retained or resected in condylar nonmeniscal knee arthroplasty? The case for resection.

M A Freeman1, G T Railton.   

Abstract

The arguments for resection of the (anterior and) posterior cruciate ligament(s), as a step in total knee arthroplasty, are reviewed on the basis of the authors' personal experience and the work of others published in the literature.

Entities:  

Mesh:

Year:  1988        PMID: 3199137     DOI: 10.1016/s0883-5403(88)80002-0

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  5 in total

1.  Posterior cruciate ligament function following total knee arthroplasty: the effect of joint line elevation.

Authors:  G J Emodi; J J Callaghan; D R Pedersen; T D Brown
Journal:  Iowa Orthop J       Date:  1999

2.  Mean tensile strength of the PCL in TKA depends on the preservation of the tibial insertion site.

Authors:  N Van Opstal; H Feyen; J P Luyckx; J Bellemans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-10-12       Impact factor: 4.342

3.  Long-term Results of Hybrid Total Knee Arthroplasty: Minimum 10-years Follow-up.

Authors:  Young Joon Choi; Ki Won Lee; Chung Hwan Kim; Hyung Sun Ahn; Jae Kwang Hwang; Jeong Ho Kang; Hee Don Han; Wan Jong Cho; Jun Seok Park
Journal:  Knee Surg Relat Res       Date:  2012-05-31

4.  Results of Total Knee Arthroplasty with NexGen LPS-flex Implant Using Navigation System (Brain Lab): Results with a 5-year Follow-up.

Authors:  Chul Hyung Kang; Kyung Jae Lee; Ki Cheor Bae; Chul Hyun Cho; Si Wook Lee; Hong Kwan Shin; Young Kook Lee; Ji Suk Bae
Journal:  Knee Surg Relat Res       Date:  2012-11-29

5.  Clinical and radiological results of cruciate-retaining total knee arthroplasty with the NexGen®-CR system: comparison of patellar resurfacing versus retention with more than 14 years of follow-up.

Authors:  Keun Churl Chun; Sung Hyun Lee; Jong Seok Baik; Seng Hwan Kook; Joung Kyue Han; Churl Hong Chun
Journal:  J Orthop Surg Res       Date:  2017-10-02       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.